2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Monday, May 1, 2017

5:42pm-5:54pm: Immunodominant Donor Specific Antibody Reduction with Proteasome Inhibitor Based Treatment: Clinical Variability and Implications for Long Term Graft Survival.

A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² B. Abu Jawdeh,¹ B. Hardy,¹ M. Anand,¹ M. Cuffy,¹ M. Cardi,¹ R. Alloway,¹ E. Woodle.¹

Concurrent Session: Antibody Mediated Rejection in Kidney Transplant Recipients: Pathophsiology and Epidimiology • E354a

5:42pm-5:54pm: Outcomes of Infrainguinal Revascularization in Renal Transplant Patients.

R. Craig-Schapiro, B. Nejim, M. Malas.

Concurrent Session: Kidney: Cardiovascular and Metabolic • E451b

5:42pm-5:54pm: Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient and Allograft Survival in Long-Term Follow-Up After Kidney Transplantation.

T. Schachtner,^1,2,3 P. Reinke.^1,2

Concurrent Session: Disparities in Organ Transplantation • E353C

5:42pm-5:54pm: Simple Kidney Transplant Graft Survival (KTGS) Calculator Predicts 5- and 10-Year Allograft Survival.

P. Sood,¹ W. Cherikh,² R. Mehta,¹ A. Tevar,¹ S. Hariharan.¹

Concurrent Session: Kidney Clinical Complications 2 • E354b

5:42pm-5:54pm: The Degree of NK Cell Activation Determines the Ability of Donor-Specific Antibodies to Mediate Acute vs. Chronic Rejection of Kidney Allografts.

T. Yagisawa,^1,2 T. Tanaka,¹ N. Dvorina,¹ A. Valujskikh,¹ W. Baldwin 3rd,¹ R. Fairchild.¹

Concurrent Session: Basic Chronic Rejection • E351

5:42pm-5:54pm: TIM-4 Identifies Pro-Inflammatory B Effector Cells That Are Potent Drivers of Alloimmunity and Allograft Rejection Through Expression of Both IFN-γ and IL-17.

Q. Ding, K. Mohib, D. Rothstein.

Concurrent Session: B Cells and Antibody in Rejection • E350

6:00pm-7:00pm: 10 Years of DTAC Experience with Kaposi's Sarcoma – Not Just Another PTLD!

M. Nalesnik,¹ M. Clark,² S. Tlusty,² M. Michaels,¹ C. Wolfe.¹

Poster Session C: PTLD/Malignancies • Hall D1

6:00pm-7:00pm: A Comparative Study of Patient and Graft Qualities Between Abo-Compatible and -Incompatible Recipients More Than Ten Years After Kidney Transplantation.

H. Ishida, T. Shimizu, M. Okumi, K. Unagami, K. Omoto, K. Tanabe.

Poster Session C: Kidney Complications III • Hall D1

6:00pm-7:00pm: A Composite Score Associated with Spontaneous Operational Tolerance in Kidney Transplant Recipients.

R. Danger,¹ M. Chesneau,¹ C. Paul,¹ P. Guérif,¹ M. Durand,¹ K. Newell,² S. Kanaparthi,³ L. Turka,⁴ J.-P. Soulillou,¹ R. Houlgatte,⁵ M. Giral,^1,6 G. Ramstein,⁷ S. Brouard.^1,6

Poster Session C: Tolerance/Immune Regulation • Hall D1

6:00pm-7:00pm: A Multicenter, Prospective and Randomized Trial Comparing Pancreas versus Islet Transplantation: Should We Do It Now?

D. Cantarovich, P.-Y. Benhamou.

Poster Session C: Pancreas and Islet (Auto and Allo) Transplantation • Hall D1